Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Reducing symptom burden in patients with myeloproliferative neoplasms in the era of Janus kinase inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences